October 10, 2026 | Arnold Building, Behnke Suites, Fred Hutch South Lake Union Campus

2026 Pacific Northwest Head & Neck Cancer Symposium: Updates in the Management of Head and Neck Cancer

Advance your clinical practice at the Pacific Northwest Head and Neck Cancer Symposium, an in‑person, multidisciplinary educational program hosted at Fred Hutch Cancer Center. This fall symposium will feature expert-led updates on emerging immunotherapy data, radiotherapy innovations, management of thyroid and salivary gland malignancies, and advances in surgical ablation and reconstruction. Designed for healthcare professionals involved in head and neck cancer care, the program emphasizes evidence-based, real‑world clinical decision-making.


Register to engage with regional experts, collaborate with colleagues, and earn continuing education credit while enhancing patient care.

Intended Audience

This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, allied health professionals, and residents interested in comprehensive clinical updates on the latest advancements in head and neck cancer treatment.

Learning Objectives

Upon completion of this activity, learners should be able to:

  1. Explain recently published neoadjuvant and adjuvant immune checkpoint inhibitor trials and illustrate relevant clinical decision-making in selected mucosal and cutaneous squamous cell carcinoma patients. 
  2. Assess updates in the management of salivary gland cancers, including indications for proton and neutron radiotherapy. 
  3. Analyze recently-published studies in the management of well-differentiated and anaplastic thyroid cancers. 
  4. Evaluate innovations in surgical ablation and reconstruction. 
  5. Manage implicit bias in the diagnosis and management of head and neck cancers. 

 

Location

Arnold Building | Behnke Suites

1100 Fairview Ave N
Seattle, WA 98109

Accreditation

In support of improving patient care, the University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Washington School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

CE Accreditation Provider approved by the California Board of Registered Nursing, Provider #16496, for 7.8 Contact Hours.